European Journal of Preventive Cardiology

Scope & Guideline

Championing excellence in preventive cardiology research.

Introduction

Welcome to the European Journal of Preventive Cardiology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of European Journal of Preventive Cardiology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2047-4873
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1999 to 2000, from 2003 to 2024
AbbreviationEUR J PREV CARDIOL / Eur. J. Prev. Cardiol.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The European Journal of Preventive Cardiology focuses on advancing the understanding and practice of preventive cardiology through rigorous research. The journal aims to disseminate knowledge related to cardiovascular disease prevention, risk assessment, and management strategies.
  1. Cardiovascular Risk Assessment and Prediction:
    The journal emphasizes the development and validation of cardiovascular risk prediction models, addressing the challenges in predicting outcomes across diverse populations.
  2. Lifestyle and Behavioral Interventions:
    A significant focus is placed on lifestyle modifications, including exercise, dietary changes, and psychosocial factors, which are crucial for the prevention and management of cardiovascular diseases.
  3. Pharmacological Interventions:
    Research on the efficacy and safety of various pharmacological treatments, particularly lipid-lowering therapies and antihypertensives, is a central theme.
  4. Epidemiology and Public Health:
    The journal publishes studies that explore the epidemiology of cardiovascular diseases, highlighting trends, risk factors, and the impact of social determinants on cardiovascular health.
  5. Innovative Therapeutic Approaches:
    There is a keen interest in exploring novel therapeutic strategies, including the use of emerging drugs and technologies in the prevention and treatment of cardiovascular diseases.
  6. Interdisciplinary Approaches:
    The journal promotes interdisciplinary research involving cardiology, endocrinology, nephrology, and other fields to address the multifactorial nature of cardiovascular diseases.
The European Journal of Preventive Cardiology is witnessing a dynamic shift towards several emerging themes that reflect current trends in cardiovascular research and public health.
  1. Holistic and Multidisciplinary Approaches:
    Research is increasingly focusing on holistic strategies that incorporate physical, mental, and social health perspectives in cardiovascular prevention and rehabilitation.
  2. Digital Health and Telemedicine:
    There is a growing interest in the application of digital health technologies and telemedicine in cardiovascular care, especially in the context of the COVID-19 pandemic.
  3. Personalized Medicine:
    Emerging themes include the personalization of cardiovascular prevention strategies based on genetic, metabolic, and lifestyle factors, aiming to tailor interventions to individual patient needs.
  4. Environmental and Socioeconomic Impacts:
    Studies exploring the impact of environmental factors, such as air pollution and socioeconomic status, on cardiovascular health are gaining prominence.
  5. Women’s Cardiovascular Health:
    There is an increasing focus on women's cardiovascular health, addressing specific risk factors, outcomes, and preventive strategies tailored for women.
  6. Integration of AI and Machine Learning:
    Research exploring the use of artificial intelligence and machine learning in predicting cardiovascular risk and outcomes is emerging as a significant trend.

Declining or Waning

While the journal continues to publish a wide range of topics, certain areas of focus appear to be waning in prominence based on recent publication trends.
  1. Traditional Risk Factors:
    Research centered around traditional cardiovascular risk factors such as cholesterol levels and hypertension management is becoming less prevalent, as newer studies focus on integrated and holistic approaches.
  2. Single-Disease Studies:
    There is a noticeable decline in studies that examine cardiovascular diseases in isolation, with a shift towards understanding comorbidities and the interplay between multiple health conditions.
  3. Basic Science Research:
    The journal's focus on basic science research related to cardiovascular biology has decreased, as there is a greater emphasis on clinical and translational research that addresses real-world applications.
  4. Acute Cardiovascular Events:
    The emphasis on acute cardiovascular events, such as myocardial infarction, is diminishing, with more attention being directed towards preventive strategies and long-term management.

Similar Journals

CANADIAN JOURNAL OF CARDIOLOGY

Empowering Cardiovascular Innovations Through Rigorous Research
Publisher: ELSEVIER SCIENCE INCISSN: 0828-282XFrequency: 12 issues/year

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

COR ET VASA

Bridging the gap between research and clinical practice in cardiology.
Publisher: CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERYISSN: 0010-8650Frequency: 6 issues/year

COR ET VASA is a prominent peer-reviewed journal in the field of cardiology and cardiovascular medicine, published by the Czech Society of Cardiology and Czech Society of Cardiovascular Surgery. Established in 1961, and continuing its legacy from 2006 to 2024, this journal serves as an essential platform for disseminating significant research findings, clinical studies, and innovative treatments in cardiovascular health. While currently positioned in the Q4 quartile, the journal aims to enhance its impact by fostering knowledge sharing among researchers, clinicians, and students alike. The journal, with its publication in Czech Republic, provides a unique perspective to the European cardiovascular community, allowing for invaluable insights and discourse. Researchers are encouraged to submit their manuscripts and contribute to the growing body of knowledge in this critical area, although it should be noted that COR ET VASA does not offer open access options at this time. As the field of cardiovascular medicine evolves, COR ET VASA remains committed to addressing the latest challenges and advancements, nurturing a rich dialogue within the community.

CIRCULATION

Unveiling Breakthroughs in Cardiovascular Science.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

Acta Cardiologica Sinica

Fostering Innovation in Cardiovascular Medicine.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

Clinica e Investigacion en Arteriosclerosis

Fostering collaboration in cardiology and pharmacology advancements.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Nepalese Heart Journal

Exploring Innovations in Heart Disease Management
Publisher: CARDIAC SOC NEPALISSN: 2091-2978Frequency: 1 issue/year

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.

Netherlands Heart Journal

Leading the Way in Cardiovascular Research and Practice
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

American Journal of Preventive Cardiology

Advancing the Future of Heart Health.
Publisher: ELSEVIERISSN: 2666-6677Frequency: 4 issues/year

American Journal of Preventive Cardiology, published by ELSEVIER, is a premier Open Access journal that has been making significant strides in the field of cardiology since its inception in 2020. With an impressive impact factor and recognized as a Q1 journal in the Cardiology and Cardiovascular Medicine category as of 2023, it ranks 77th out of 387 in the Scopus database, placing it in the 80th percentile of its field. The journal aims to promote the latest research and practices in preventive cardiology, addressing the global burden of cardiovascular diseases through a combination of innovative findings and practical applications. With the advantage of Open Access, all published articles are readily available to researchers, professionals, and students worldwide, fostering a broad dissemination of knowledge and encouraging collaboration across disciplines. Based in Amsterdam, Netherlands, the journal is committed to advancing the science and prevention of heart disease, making it an essential resource for those dedicated to improving cardiovascular health.

CIRCULATION JOURNAL

Empowering Cardiovascular Innovation Through Open Access.
Publisher: JAPANESE CIRCULATION SOCISSN: 1346-9843Frequency: 12 issues/year

CIRCULATION JOURNAL, published by the Japanese Circulation Society, stands as a premier platform for cutting-edge research in the fields of Cardiology and Cardiovascular Medicine. With an impressive impact factor placing it in the Q1 quartile for both cardiology and general medicine, this journal is essential for researchers and practitioners seeking to stay at the forefront of cardiovascular science. The journal's accessible open access options ensure that groundbreaking studies are widely disseminated, reflecting its commitment to advancing medical knowledge and improving patient care. Since its inception in 1996, CIRCULATION JOURNAL has fostered a global dialogue on vital cardiovascular issues, making it a vital resource for academics, healthcare professionals, and students alike. With its base in Tokyo, Japan, the journal not only highlights regional advancements but also contributes significantly to the global medical community.

Indian Heart Journal

Elevating Cardiovascular Research to New Heights
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.